KO2 Stock Overview
Provides care home, healthcare facilities and services, and shared living solutions in France, Germany, Benelux, Italy, Spain, and the United Kingdom. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Clariane SE Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €3.87 |
| 52 Week High | €4.92 |
| 52 Week Low | €1.55 |
| Beta | 0.84 |
| 1 Month Change | 4.70% |
| 3 Month Change | 64.85% |
| 1 Year Change | 59.03% |
| 3 Year Change | -80.39% |
| 5 Year Change | -87.42% |
| Change since IPO | -89.81% |
Recent News & Updates
Recent updates
Shareholder Returns
| KO2 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 9.0% | 4.4% | 3.4% |
| 1Y | 59.0% | 35.1% | 15.0% |
Return vs Industry: KO2 exceeded the German Healthcare industry which returned 33.6% over the past year.
Return vs Market: KO2 exceeded the German Market which returned 14.4% over the past year.
Price Volatility
| KO2 volatility | |
|---|---|
| KO2 Average Weekly Movement | 12.6% |
| Healthcare Industry Average Movement | 6.2% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in DE Market | 12.9% |
| 10% least volatile stocks in DE Market | 3.1% |
Stable Share Price: KO2's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: KO2's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 61,798 | Sophie Boissard | www.clariane.com |
Clariane SE provides care home, healthcare facilities and services, and shared living solutions in France, Germany, Benelux, Italy, Spain, and the United Kingdom. The company operates long-term care and short stays nursing homes. It also provides diagnosis outpatient programs; healthcare services comprising medical and full hospitalization services, as well as day hospitalisation and consultations; and operates post-acute and rehabilitation care facilities, mental healthcare clinics, hospital home care networks, and home community nursing facilities.
Clariane SE Fundamentals Summary
| KO2 fundamental statistics | |
|---|---|
| Market cap | €1.37b |
| Earnings (TTM) | -€30.33m |
| Revenue (TTM) | €5.28b |
0.3x
P/S Ratio-45.1x
P/E RatioIs KO2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KO2 income statement (TTM) | |
|---|---|
| Revenue | €5.28b |
| Cost of Revenue | €3.59b |
| Gross Profit | €1.69b |
| Other Expenses | €1.72b |
| Earnings | -€30.33m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
Jul 29, 2025
| Earnings per share (EPS) | -0.085 |
| Gross Margin | 31.99% |
| Net Profit Margin | -0.57% |
| Debt/Equity Ratio | 98.6% |
How did KO2 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/05 15:07 |
| End of Day Share Price | 2025/05/05 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Clariane SE is covered by 17 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Fraser Donlon | Berenberg |
| Laurent Gelebart | BNP Paribas Exane |
| Bruno de La Rochebrochard | Bryan Garnier & Co |